Akila Sasantha Weerasekera, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Rheumatic Diseases | 1 | 2023 | 659 | 0.530 |
Why?
|
Low Back Pain | 1 | 2023 | 990 | 0.480 |
Why?
|
Magnetic Resonance Spectroscopy | 6 | 2024 | 3782 | 0.450 |
Why?
|
Aspartic Acid | 4 | 2024 | 577 | 0.430 |
Why?
|
Choline | 3 | 2023 | 522 | 0.400 |
Why?
|
Creatine | 3 | 2023 | 427 | 0.390 |
Why?
|
Osteoarthritis, Knee | 1 | 2021 | 1251 | 0.360 |
Why?
|
Arthroplasty, Replacement, Knee | 1 | 2021 | 1389 | 0.350 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2020 | 1475 | 0.320 |
Why?
|
Brain | 6 | 2024 | 27362 | 0.310 |
Why?
|
Nucleus Accumbens | 2 | 2022 | 358 | 0.300 |
Why?
|
Inositol | 3 | 2024 | 216 | 0.280 |
Why?
|
Central Nervous System Depressants | 2 | 2018 | 163 | 0.280 |
Why?
|
Depressive Disorder, Major | 1 | 2024 | 4818 | 0.270 |
Why?
|
Glutamic Acid | 4 | 2024 | 1191 | 0.260 |
Why?
|
Schizophrenia | 1 | 2024 | 6983 | 0.240 |
Why?
|
Glutamine | 2 | 2017 | 577 | 0.230 |
Why?
|
Caudate Nucleus | 2 | 2022 | 391 | 0.220 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2024 | 876 | 0.210 |
Why?
|
Thalamus | 3 | 2023 | 1047 | 0.190 |
Why?
|
Ethanol | 2 | 2018 | 1331 | 0.190 |
Why?
|
Gangliosidoses, GM2 | 1 | 2021 | 20 | 0.190 |
Why?
|
Body Temperature | 1 | 2024 | 780 | 0.190 |
Why?
|
Trehalose | 1 | 2020 | 88 | 0.180 |
Why?
|
Meningitis, Cryptococcal | 1 | 2020 | 67 | 0.170 |
Why?
|
Nitriles | 4 | 2018 | 980 | 0.170 |
Why?
|
Spectrum Analysis | 1 | 2021 | 449 | 0.160 |
Why?
|
Ferritins | 1 | 2021 | 601 | 0.150 |
Why?
|
Hippocampus | 3 | 2024 | 3783 | 0.150 |
Why?
|
Gyrus Cinguli | 1 | 2024 | 1135 | 0.140 |
Why?
|
Phenylurea Compounds | 1 | 2021 | 531 | 0.140 |
Why?
|
Oxidopamine | 1 | 2017 | 169 | 0.140 |
Why?
|
Dyskinesias | 1 | 2017 | 79 | 0.140 |
Why?
|
Levodopa | 1 | 2017 | 221 | 0.140 |
Why?
|
Fibromyalgia | 1 | 2021 | 407 | 0.130 |
Why?
|
Putamen | 1 | 2017 | 291 | 0.130 |
Why?
|
Magnetic Resonance Imaging | 6 | 2024 | 36741 | 0.130 |
Why?
|
Long-Term Potentiation | 1 | 2018 | 289 | 0.130 |
Why?
|
Positron-Emission Tomography | 5 | 2020 | 6669 | 0.130 |
Why?
|
Quinolines | 1 | 2021 | 772 | 0.120 |
Why?
|
Motor Cortex | 1 | 2022 | 1013 | 0.120 |
Why?
|
Exploratory Behavior | 1 | 2016 | 272 | 0.120 |
Why?
|
Cocaine-Related Disorders | 1 | 2018 | 458 | 0.120 |
Why?
|
Quinazolines | 1 | 2021 | 1373 | 0.110 |
Why?
|
Prefrontal Cortex | 3 | 2022 | 2238 | 0.110 |
Why?
|
Folic Acid | 1 | 2021 | 1337 | 0.110 |
Why?
|
Limbic System | 1 | 2016 | 424 | 0.110 |
Why?
|
Temperament | 1 | 2016 | 301 | 0.110 |
Why?
|
Pyridines | 4 | 2018 | 2894 | 0.110 |
Why?
|
Young Adult | 7 | 2024 | 60066 | 0.100 |
Why?
|
Piperidines | 1 | 2021 | 1667 | 0.100 |
Why?
|
Angiogenesis Inhibitors | 1 | 2021 | 2057 | 0.090 |
Why?
|
Synaptic Transmission | 1 | 2017 | 1177 | 0.090 |
Why?
|
Mice, Transgenic | 2 | 2020 | 9561 | 0.090 |
Why?
|
Dopamine | 1 | 2017 | 1592 | 0.090 |
Why?
|
Amygdala | 1 | 2018 | 1379 | 0.090 |
Why?
|
Drug Delivery Systems | 1 | 2021 | 2237 | 0.080 |
Why?
|
Motor Activity | 1 | 2019 | 2711 | 0.080 |
Why?
|
RNA, Viral | 1 | 2017 | 2874 | 0.080 |
Why?
|
Peptides | 1 | 2020 | 4354 | 0.070 |
Why?
|
Humans | 16 | 2024 | 768171 | 0.070 |
Why?
|
Glioblastoma | 1 | 2021 | 3464 | 0.070 |
Why?
|
Cognition | 1 | 2022 | 7073 | 0.060 |
Why?
|
Protein Kinase Inhibitors | 1 | 2021 | 5704 | 0.060 |
Why?
|
Parietal Lobe | 2 | 2021 | 866 | 0.060 |
Why?
|
Aging | 2 | 2022 | 8743 | 0.060 |
Why?
|
Adult | 6 | 2024 | 223646 | 0.060 |
Why?
|
Rats, Wistar | 2 | 2018 | 1890 | 0.050 |
Why?
|
Parkinson Disease | 1 | 2017 | 2893 | 0.050 |
Why?
|
Pandemics | 1 | 2022 | 8747 | 0.050 |
Why?
|
Sandhoff Disease | 1 | 2021 | 14 | 0.050 |
Why?
|
Animals | 8 | 2021 | 169285 | 0.050 |
Why?
|
Tay-Sachs Disease | 1 | 2021 | 20 | 0.050 |
Why?
|
Cerebral Cortex | 1 | 2017 | 5812 | 0.050 |
Why?
|
Deoxycholic Acid | 1 | 2020 | 54 | 0.050 |
Why?
|
Mice | 4 | 2020 | 82049 | 0.040 |
Why?
|
Middle Aged | 7 | 2024 | 223487 | 0.040 |
Why?
|
Amphotericin B | 1 | 2020 | 143 | 0.040 |
Why?
|
Brain Neoplasms | 1 | 2021 | 9118 | 0.040 |
Why?
|
Fluconazole | 1 | 2020 | 156 | 0.040 |
Why?
|
Horses | 1 | 2021 | 295 | 0.040 |
Why?
|
Cryptococcus neoformans | 1 | 2020 | 121 | 0.040 |
Why?
|
Receptors, GABA | 1 | 2022 | 312 | 0.040 |
Why?
|
Diffusion | 1 | 2021 | 815 | 0.040 |
Why?
|
Female | 9 | 2024 | 397187 | 0.040 |
Why?
|
Surface Properties | 1 | 2021 | 1166 | 0.040 |
Why?
|
Aged | 4 | 2024 | 171502 | 0.040 |
Why?
|
Clone Cells | 1 | 2021 | 1670 | 0.040 |
Why?
|
Moloney murine leukemia virus | 1 | 2017 | 110 | 0.030 |
Why?
|
Radiopharmaceuticals | 2 | 2017 | 2735 | 0.030 |
Why?
|
Inverted Repeat Sequences | 1 | 2017 | 60 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 1 | 2020 | 20762 | 0.030 |
Why?
|
Self Administration | 1 | 2018 | 386 | 0.030 |
Why?
|
Base Composition | 1 | 2017 | 291 | 0.030 |
Why?
|
Male | 7 | 2024 | 364731 | 0.030 |
Why?
|
Alzheimer Disease | 1 | 2018 | 8759 | 0.030 |
Why?
|
Drug Carriers | 1 | 2021 | 710 | 0.030 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2021 | 2486 | 0.030 |
Why?
|
Organ Culture Techniques | 1 | 2018 | 796 | 0.030 |
Why?
|
Pyrrolidines | 1 | 2017 | 341 | 0.030 |
Why?
|
Biological Availability | 1 | 2016 | 391 | 0.030 |
Why?
|
Cell Death | 1 | 2021 | 1680 | 0.030 |
Why?
|
Communicable Disease Control | 1 | 2022 | 857 | 0.030 |
Why?
|
Treatment Failure | 1 | 2021 | 2661 | 0.030 |
Why?
|
Thermodynamics | 1 | 2017 | 591 | 0.030 |
Why?
|
Fluorine Radioisotopes | 1 | 2018 | 425 | 0.030 |
Why?
|
Longitudinal Studies | 2 | 2021 | 14783 | 0.030 |
Why?
|
RNA Stability | 1 | 2017 | 320 | 0.030 |
Why?
|
Drug Combinations | 1 | 2020 | 2089 | 0.030 |
Why?
|
Cerebellum | 1 | 2021 | 1522 | 0.030 |
Why?
|
Nucleic Acid Conformation | 1 | 2017 | 901 | 0.030 |
Why?
|
Infusions, Intravenous | 1 | 2017 | 2230 | 0.030 |
Why?
|
Biocompatible Materials | 1 | 2021 | 1703 | 0.030 |
Why?
|
Tissue Distribution | 1 | 2016 | 2300 | 0.020 |
Why?
|
Rats | 2 | 2018 | 23782 | 0.020 |
Why?
|
Benzamides | 1 | 2017 | 1379 | 0.020 |
Why?
|
Organ Specificity | 1 | 2016 | 1968 | 0.020 |
Why?
|
Temporal Lobe | 1 | 2017 | 1726 | 0.020 |
Why?
|
Molecular Imaging | 1 | 2016 | 826 | 0.020 |
Why?
|
Cell Movement | 1 | 2021 | 5213 | 0.020 |
Why?
|
Alcoholism | 1 | 2018 | 1980 | 0.020 |
Why?
|
Acute Disease | 1 | 2017 | 7243 | 0.020 |
Why?
|
Cell Line | 1 | 2021 | 15602 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2019 | 7140 | 0.020 |
Why?
|
Base Sequence | 1 | 2017 | 12422 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 15453 | 0.020 |
Why?
|
Blood Glucose | 1 | 2018 | 6431 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2021 | 9419 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2016 | 14729 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2018 | 22380 | 0.010 |
Why?
|
Cohort Studies | 1 | 2021 | 41753 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2017 | 18349 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2016 | 20225 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2021 | 13677 | 0.010 |
Why?
|
Prospective Studies | 1 | 2021 | 54924 | 0.010 |
Why?
|